
Public-private partnerships will crumble, hurting drug innovation and eventually patients, Republicans say.
Richard Payerchin is editor of Medical Economics.

Public-private partnerships will crumble, hurting drug innovation and eventually patients, Republicans say.

December meeting has two days of discussion planned.

Move would save lives, but administration punts to 2024.

The top news stories in primary care today.

National Institutes of Health announce program as potential model for future care.

Representatives examining how administration experts develop American leadership in technology.

‘The results are alarming,’ with potential financial effects for patients and pharmacies, researchers say.

The top news stories in primary care today.

Regulators ponder declaration about in vitro diagnostic products.

The top news stories in primary care today.

Double dose against respiratory illness may be more convenient for patients.

The top news stories in primary care today.

Value-based care to launch in eight states in July next year.


New director testifies on her plans, agency strengths, and areas for improvement before House subcommittee.

KFF chief says affordability is part of national crisis in U.S. economy.

Mounting pressures have plunged physicians into a crisis, underscoring the need for comprehensive reform.

National Press Club learns about issues affecting a ‘health care system in crisis.’

House bill gains bipartisan support, along with praise from medical organizations.

Researchers examine long-term benefits for patient hearts, cancer risk, and lungs.

University of Kentucky announces financial aid for Rural Physician Leadership Program.

Practical steps for establishing relationships.

Researchers say more physicians prescribing buprenorphine could help stem the overdose crisis across the country.

Physicians aren’t the only ones waiting on health insurance companies to pay.

How could artificial intelligence help in medicine?

Experts weigh in on current factors affecting the job market.

Wrong claims exploded during the COVID-19 pandemic. Interventions helped spread the facts and create a base for future efforts.

A team effort is needed to promote patient health.

Urology group leader explains why now is the time to reconsider USPSTF recommendations on screening in men.

Class action complaint could involve thousands of people in 21 states.